Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 1,045,339	$ 2,269,756
Trade accounts receivable, less allowance for doubtful accounts (2017 – $6,378; 2016 – $15,312)	520,076	486,035
Other accounts receivable	50,071	41,985
Inventories	610,212	450,263
Other current assets	101,626	58,579
Total current assets	2,327,324	3,306,618
Property, plant and equipment, at cost	4,167,065	3,910,522
Less accumulated depreciation and amortization	1,682,780	1,550,382
Net property, plant and equipment	2,484,285	2,360,140
Investments	530,227	457,533
Other assets	148,573	142,320
Goodwill	1,616,478	1,540,032
Other intangibles, net of amortization	416,413	354,564
Total assets	7,523,300	8,161,207
Current liabilities:
Accounts payable	361,937	281,874
Accrued expenses	276,953	322,165
Current portion of long-term debt	382,358	247,544
Dividends payable	35,142	34,104
Income taxes payable	46,627	254,416
Total current liabilities	1,103,017	1,140,103
Long-term debt	1,407,171	2,121,718
Postretirement benefits	50,446	50,538
Pension benefits	309,787	298,695
Other noncurrent liabilities	199,273	194,810
Deferred income taxes	414,034	412,739
Commitments and contingencies (Note 11)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 110,495 in 2017 and 112,524 in 2016	1,105	1,125
Additional paid-in capital	1,858,753	2,084,418
Accumulated other comprehensive loss	(249,943)	(412,412)
Retained earnings	2,288,904	2,121,931
Total Albemarle Corporation shareholders’ equity	3,898,819	3,795,062
Noncontrolling interests	140,753	147,542
Total equity	4,039,572	3,942,604
Total liabilities and equity	$ 7,523,300	$ 8,161,207